JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Contingent Liabilities History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Contingent Liabilities | ₹11 Cr | ₹6.09 Cr | ₹7.96 Cr | ₹8.08 Cr | ₹6.06 Cr |
What is the latest Contingent Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
Year | Contingent Liabilities |
---|---|
Mar2024 | ₹11 Cr |
Mar2023 | ₹6.09 Cr |
Mar2022 | ₹7.96 Cr |
Mar2021 | ₹8.08 Cr |
Mar2020 | ₹6.06 Cr |
How is Contingent Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
Years | Contingent Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹11 Cr | 84.29 | |
Mar2023 | ₹6.09 Cr | -23.57 | |
Mar2022 | ₹7.96 Cr | -1.44 | |
Mar2021 | ₹8.08 Cr | 33.42 | |
Mar2020 | ₹6.06 Cr | - |
Compare Contingent Liabilities of peers of JAGSONPAL PHARMACEUTICALS
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
JAGSONPAL PHARMACEUTICALS | ₹1,358.9 Cr | -18.3% | -5% | 53.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹418,648.0 Cr | -4.9% | 2.1% | 15.5% | Stock Analytics | |
DIVIS LABORATORIES | ₹159,310.0 Cr | -2.2% | 9.3% | 50.5% | Stock Analytics | |
CIPLA | ₹119,410.0 Cr | -4.2% | 4.5% | 4.5% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹106,189.0 Cr | -4.4% | -4.5% | 17.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹96,496.4 Cr | -1.4% | 4.2% | -8.8% | Stock Analytics |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
JAGSONPAL PHARMACEUTICALS | -18.3% |
-5% |
53.3% |
SENSEX | -1.3% |
4.1% |
7.6% |
You may also like the below Video Courses